{{no footnotes|time=2017-12-24T17:40:59+00:00}}
{{refimprove|time=2017-12-24T17:40:59+00:00}}
{{medical}}
{{Drugbox
| verifiedrevid = 443510665
| IUPAC_name = (6''R'',7''R'')-7-([(''Z'')-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl]amino) -8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
| image = Ceftibuten-Formulae.png
| width = 300

<!--Clinical data-->
| tradename = Cedax
| Drugs.com = {{drugs.com|monograph|ceftibuten}}
| MedlinePlus = a698023
| pregnancy_category =  
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| excretion =

<!--Identifiers-->
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 97519-39-6
| ATC_prefix = J01
| ATC_suffix = DD14
| PubChem = 5282242
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01415
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4445419
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = IW71N46B4Y
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00922
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 3510
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1605

<!--Chemical data-->
| C=15 | H=14 | N=4 | O=6 | S=2 
| molecular_weight = 410.427 g.mol<sup>-1</sup>
| smiles = O=C2N1/C(=C\CS[C@@H]1[C@@H]2NC(=O)C(=C/CC(=O)O)\c3nc(sc3)N)C(=O)O
| InChI = 1/C15H14N4O6S2/c16-15-17-7(5-27-15)6(1-2-9(20)21)11(22)18-10-12(23)19-8(14(24)25)3-4-26-13(10)19/h1,3,5,10,13H,2,4H2,(H2,16,17)(H,18,22)(H,20,21)(H,24,25)/b6-1-/t10-,13-/m1/s1
| InChIKey = UNJFKXSSGBWRBZ-BJCIPQKHBU
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C15H14N4O6S2/c16-15-17-7(5-27-15)6(1-2-9(20)21)11(22)18-10-12(23)19-8(14(24)25)3-4-26-13(10)19/h1,3,5,10,13H,2,4H2,(H2,16,17)(H,18,22)(H,20,21)(H,24,25)/b6-1-/t10-,13-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = UNJFKXSSGBWRBZ-BJCIPQKHSA-N
}}

'''头孢布烯(英文:Ceftibuten)''' 是第三代[[头孢菌素|头孢菌素]][[抗生素|抗生素]]。它是一种口服给药药剂，有两种类型，分别为胶囊或口服悬浮液。它是由Pernix Therapeutics以Cedax的商品名销售。

==临床使用==
{{main|头孢菌素}}

===适应症===
头孢布烯用于治疗急性细菌恶化[[慢性支气管炎|慢性支气管炎]]（ABECB），急性细菌性[[中耳炎|中耳炎]]，[[咽喉炎|咽喉炎]]和[[扁桃体炎|扁桃体炎]]。它也可用于为[[肺炎|肺炎]]，[[尿道|尿道]]感染，[[肠炎|肠炎]]和[[胃肠炎|胃肠炎]]。{{Citation needed|date=May 2009}}<!--

===Adverse reactions===
In 3,000 patients, ceftibuten was well tolerated. The most frequent reactions were gastrointestinal and nauseas.

===Formulations===
Ceftibuten is available as capsules containing 400 mg, and a powder for oral suspension containing 180 mg per 5 ml.

==Spectrum of susceptibility==
Ceftibuten is active against ''[[Haemophilus_influenzae|Haemophilus influenzae]]'', ''[[Moraxella_catarrhalis|Moraxella catarrhalis]]'', ''[[Escherichia_coli|Escherichia coli]]'', ''K. pneumoniae'', ''K. oxytoca'', ''[[Proteus_vulgaris|Proteus vulgaris]]'', ''P. mirabilis'', ''P. providence'', ''[[Salmonella|Salmonella]]'' sp., ''[[Shigella|Shigella]]'' sp., ''[[Enterobacter|Enterobacter]]'' sp. and ''[[Streptococcus|Streptococcus]]'' sp.

The following represents MIC susceptibility data for a few clinically significant microorganisms:
* ''Haemophilus influenzae'' - 0.015 µg/mL - 1 µg/mL
* ''Moraxella catarrhalis'' - 0.5 µg/mL - 4 µg/mL
* ''Streptococcus pneumoniae'' - 0.5 µg/mL - >256 µg/mL <ref>http://www.toku-e.com/Assets/MIC/Ceftibuten.pdf</ref>-->

==参考资料==
{{Reflist}}

==外部链接==
*[http://www.pernixtx.com/cedax/ Manufacturer's website]{{Wayback|url=http://www.pernixtx.com/cedax/ |date=20131210065906 }}
*[https://web.archive.org/web/20070205175626/http://www.rxlist.com/cgi/generic2/ceftibuten.htm Drug information from RxList]

{{CephalosporinAntiBiotics}}

[[Category:頭孢菌素|Category:頭孢菌素]]
[[Category:Thiazoles|Category:Thiazoles]]